Filter
4646
Filtered Results: 4646
Text search:
health
service
administration
Featured
Recommendations
429
New Publications
1317
Language
Document type
No document type
2737
Guidelines
665
Studies & Reports
638
Manuals
267
Strategic & Response Plan
152
Training Material
70
Fact sheets
59
Situation Updates
31
Resource Platforms
9
Brochures
7
Infographics
7
Online Courses
3
Videos
1
Countries / Regions
India
236
Global
157
Kenya
151
Ethiopia
140
South Africa
100
Myanmar / Burma
94
Nepal
93
Nigeria
92
Uganda
91
Liberia
81
Tanzania
80
Western and Central Europe
78
Rwanda
76
Zambia
72
Latin America and the Carribbean
70
Sierra Leone
67
Bangladesh
67
Malawi
62
Ghana
61
Philippines
49
Africa
48
Ukraine
43
Syria
41
Congo, Democratic Republic of
40
Senegal
39
Namibia
34
Zimbabwe
33
Haiti
33
Eastern Europe
33
Indonesia
29
Cambodia
26
South Sudan
25
Lesotho
25
Guinea
24
Burkina Faso
24
Mozambique
24
Cameroon
23
Botswana
23
South–East Asia Region
23
Venezuela
23
USA
22
Benin
22
West and Central Africa
20
Middle East and North Africa
19
Asia
19
Russia
19
Madagascar
18
East and Southern Africa
17
Eswatini/ Swaziland
16
Germany
14
Brazil
14
Thailand
13
Central African Republic
12
Yemen
12
Eastern Europe and Central Asia
12
Pakistan
11
Afghanistan
11
Mali
10
Colombia
10
Somalia
9
Lebanon
9
China
9
Sudan
9
Tajikistan
9
Jordan
8
Peru
8
Vietnam
8
Côte d’Ivoire / Ivory Coast
7
Iraq
7
Argentina
7
Paraguay
7
Laos
7
Moldova
7
Ecuador
6
Western Pacific Region
6
Iran
6
Turkey
5
Chad
5
Papua New Guinea
5
Angola
5
Sri Lanka
5
Albania
5
Southern Africa
5
Georgia
5
Niger
4
Togo
4
North Macedonia
4
Libya
4
Poland
4
Timor Leste/ East Timor
4
Spain
4
Morocco
3
Serbia
3
Mexico
3
Chile
3
Bhutan
3
Romania
3
North America
3
Japan
3
United Kingdom
3
Portugal
3
Guinea-Bissau
2
Saudi Arabia
2
Egypt
2
Gambia
2
Malaysia
2
Singapore
2
Hungary
2
Croatia
2
Bolivia
2
Palestine
2
Estonia
2
Lithuania
2
Kyrgyzstan
2
Kazakhstan
2
Turkmenistan
2
Jamaica
2
Israel
2
Mauritania
1
Vanuatu
1
Dominican Republic
1
Switzerland
1
Burundi
1
El Salvador
1
Greece
1
Guatemala
1
Solomon Islands
1
North Korea
1
Qatar
1
Slovakia
1
Australia
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Azerbaijan
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
1918
Clinical Guidelines
442
Women & Child Health
230
Public Health
228
Key Resources
206
Capacity Building
74
Pharmacy & Technologies
53
General Guidelines
1
Toolboxes
Mental Health
382
COVID-19
351
HIV
247
TB
236
Caregiver
165
AMR
161
NTDs
147
Disability
141
Rapid Response
138
Pharmacy
126
Ebola
104
Planetary Health
99
Conflict
89
Refugee
74
Natural Hazards
65
NCDs
54
Health Financing Toolbox
47
Global Health Education
44
Specific Hazards
31
Cholera
27
Polio
27
Zika
20
Social Ethics
19
Health Financing
3
Typhoon
1
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
La schistosomiase humaine est une maladie parasitaire chronique et aigüe causée par une infection par des douves du sang (vers trématodes) du genre Schistosoma. Cette maladie est un problème de santé publique dans les zones tropicales et
subtropicales d’Afrique, d’Asie, des Caraïbes et d...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
During the 17 years since Surgical approaches to the urogenital manifestations of lymphatic filariasis was first published, there has been heightened awareness of the physical, economic and emotional burden of the genitourinary manifestations of filariasis. With the impetus to provide better guidanc...
Driving progress towards rabies elimination: Results of Gavi’s Learning Agenda on rabies and new WHO position on rabies immunization
Il s’agit du premier rapport d’une collection de l’OMS intitulée De l’intention à l’action, qui vise à renforcer la base de données probantes sur l’impact de la participation significative et à combler le manque d’approches normalisées pour permettre la participation significativ...
В дорожной карте по борьбе с забытыми тропическими болезнями на 2021–2030 гг. («дорожная карта») определены глобальные цели и основные этапы в отношении борьбы с 20 бол...
Safe drinking-water management must consider drinking-water quality, acceptability and quantity in the context of public health protection. In this manual, the term “safety” encompasses these three elements. Although the principles in this manua...
The content of these guidelines goes beyond the technicalities of medical needs with additional insights into community empowerment, possible access to welfare and economic opportunities and similar issues. If these are adequately explored, the health...
This report highlights the work of the World Health Organization (WHO) in Zimbabwe towards contributing to the triple billion targets in the context of the Sustainable Development Goals (SDGs
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
This report compiles data for the first time on the far-reaching consequences of uncontrolled hypertension, including heart attacks, strokes and premature death, along with substantial economic losses for communities and countries. It also contains information on the global, regional and country-lev...
This action plan is intended for senior-level decision-makers in ministries of health, malaria
programme managers, entomologists, and epidemiologists working on malaria and other vectorborne diseases programmes. It is also intended for decision-mak...
A year ago, the second Special Session of the World Health Assembly (WHASS) unanimously agreed to start a diplomatic process for a new binding instrument aimed at ensuring the international community is better prepared for the next ... emergencies. The establishment of an Intergovernmental Negotiating Body (INB) at the WHO paved the terrain for a proper negotiation, which has started to unfold. The INB will be releasing the “conceptual zero draft” of the treaty text in early December 2022.
This technical report has been developed within the framework of the WHO Global Initiative for
Childhood Cancer. Its goal is to improve the situation of children and adolescents with cancer worldwide,
giving them the best chances of survival, living a full life and, above all, enjoying quality of ...
Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
Caring for burns patients from the incident scene to definitive treatment can be a complex, resource-consuming process with the potential to overwhelm health system capacity.This document provides practical guidance for building capacity and capabil...
